Development of novel vaccine candidates and challenge models for Plasmodium vivax
Plasmodium vivax is the most widely distributed human malaria parasite in the world and despite nearly 2.5 billion people living at risk, only four vaccines have been assessed in phase I clinical trials and only one has progressed to a phase II trial showing no sterile efficacy. We started to develo...
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Journal article |
| Julkaistu: |
BioMed Central
2014
|